Medical Properties Trust (MPT) AI Stock Analysis

• Market Cap: $3.15B
• Dividend Yield: 6.57%
• Average Volume (3M): 5.50M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.86
• Revenue Growth: 45.56%
• EPS Growth: 73.44%
• Country: US
• Employees: 118
• Sector: Real Estate
• Sector Strength: 53
• Industry: REIT - Industrial
• EPS (TTM): -0.13
• Shares Outstanding: 601,500,000
• 10 Day Avg. Volume: 6,232,327
• 30 Day Avg. Volume: 5,497,569
• PEG Ratio: >-0.01
• Price to Book (P/B): 0.49
• Price to Sales (P/S): 2.38
• P/FCF Ratio: 9.66
• Enterprise Value/Market Cap: 3.97
• Enterprise Value/Revenue: 13.36
• Enterprise Value/Gross Profit: 16.33
• Enterprise Value/Ebitda: 17.91
• 1Y Price Target: $5.50
• Price Target Upside: 4.96% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 4
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 48 Neutral
• Price Target: $5.00 ▼(-4.58% Downside)

Overall score is pulled down primarily by weakened financial performance (net losses, rising leverage, and declining operating cash flow). Technicals are neutral-to-soft and valuation is supported by the high yield but constrained by loss-driven negative P/E. Earnings call commentary was mixed, balancing improving tenant performance and buyback authorization against impairments and rent-timing/tenant risks.

Positive Factors

Business Model Strength

The triple-net lease model ensures stable rental income, as tenants cover property taxes, insurance, and maintenance, reducing operational risk.

Strategic Partnerships

Partnerships with top healthcare operators enhance occupancy and cash flow reliability, supporting long-term revenue stability and growth.

Share Repurchase Program

The share repurchase reflects management's confidence in the business model and can improve shareholder value by reducing share count.

Negative Factors

High Leverage

High leverage increases financial risk and limits flexibility, potentially impacting the company's ability to invest in growth opportunities.

Declining Revenue

Declining revenue trends indicate potential challenges in maintaining market position and could pressure profitability if not reversed.

Prospect Bankruptcy

The bankruptcy of a major tenant like Prospect can lead to financial impairments and uncertainty in cash flow, affecting overall stability.

Medical Properties Trust Business Overview & Revenue Model

Company Description

Medical Properties Trust, Inc. is a self-advised real estate investment trust. It engages in the investment, acquisition, and development of net-leased healthcare facilities. Its property portfolio includes rehabilitation hospitals, long-term acute care hospitals, ambulatory surgery centers, hospitals for women and children, regional and community hospitals, medical office buildings, and other single-discipline facilities. The company was founded by Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie in 2003 and is headquartered in Birmingham, AL.

How the Company Makes Money

Medical Properties Trust generates revenue primarily through long-term leases with healthcare operators. The company acquires healthcare facilities and then leases them to operators under triple-net leases, where the tenant is responsible for property taxes, insurance, and maintenance costs. This structure allows MPW to receive stable, predictable rental income. Key revenue streams include rent payments from a diverse portfolio of properties, which includes acute care hospitals and other specialized healthcare facilities. Additionally, MPW may benefit from strategic partnerships with well-established healthcare operators, which can enhance occupancy rates and rental income. The company's revenue is further supported by its ability to acquire properties in attractive markets, providing a solid foundation for sustainable earnings growth.

Medical Properties Trust Financial Statement Overview

Summary

Financials are stressed: profitability swung to large net losses in 2023–TTM, leverage has risen materially (debt-to-equity ~2.06 TTM), and operating cash flow has trended down sharply (2023 to TTM). Positives include still-positive EBITDA and recent positive free cash flow, but the overall trajectory remains weak and risk-sensitive.

Income Statement

Revenue has been volatile—down sharply in 2023, partially rebounding in 2024 and TTM (Trailing-Twelve-Months). Profitability has deteriorated materially, with large net losses in 2023–2025 TTM after positive earnings in 2020–2022. While gross profit remains very high (typical for many REIT income statement presentations) and EBITDA is still positive, the swing to deep net losses and weaker earnings trajectory weighs heavily on the quality of results.

Balance Sheet

Leverage is elevated and has trended worse versus equity, with debt-to-equity rising to ~2.06 in TTM (Trailing-Twelve-Months) from ~1.34 in 2023. Equity has also declined versus prior years (notably below 2021–2022 levels), and returns on equity are meaningfully negative in 2023–TTM, reflecting the income statement losses. Offsetting this, the company still reports substantial equity and asset base, but the balance sheet risk profile is clearly higher today than a few years ago.

Cash Flow

Operating cash flow remains positive, but it has compressed significantly (from $506M in 2023 to $245M in 2024 and $147M in TTM (Trailing-Twelve-Months)), and free cash flow has been inconsistent (large deficits in 2020 and 2022, positive in 2021, 2023–TTM). Cash generation versus operating profitability has also weakened, with operating cash flow covering only ~0.26x of EBIT in TTM (Trailing-Twelve-Months). The main positive is that the most recent periods still show positive free cash flow, but the downtrend and volatility are notable risks.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	936.95M	995.55M	871.80M	1.54B	1.54B	1.25B
Gross Profit	766.57M	968.29M	830.23M	1.50B	1.51B	1.22B
EBITDA	699.12M	840.60M	697.41M	1.35B	1.37B	1.10B
Net Income	-707.43M	-2.41B	-556.48M	902.60M	656.02M	431.45M
Balance Sheet
Total Assets	14.92B	14.29B	18.30B	19.66B	20.52B	16.83B
Cash, Cash Equivalents and Short-Term Investments	396.58M	332.33M	250.02M	235.67M	459.23M	549.88M
Total Debt	9.76B	8.98B	10.22B	10.41B	11.37B	9.01B
Total Liabilities	10.26B	9.46B	10.67B	11.06B	12.07B	9.49B
Stockholders Equity	4.66B	4.83B	7.63B	8.59B	8.44B	7.34B
Cash Flow
Free Cash Flow	147.39M	245.48M	505.79M	-801.35M	746.11M	-3.67B
Operating Cash Flow	147.39M	245.48M	505.79M	739.01M	811.66M	617.64M
Investing Cash Flow	-165.13M	1.32B	517.56M	396.06M	-3.86B	-2.95B
Financing Cash Flow	137.26M	-1.48B	-1.02B	-1.34B	2.95B	1.40B

Medical Properties Trust Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 5.24
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MPT, the sentiment is Positive. The current price of 5.24 is above the 20-day moving average (MA) of 5.19, above the 50-day MA of 5.22, and above the 200-day MA of 4.73, indicating a bullish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 55.10 is Neutral, neither overbought nor oversold. The STOCH value of 75.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MPT.

Medical Properties Trust Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CTRE	80 Outperform	$8.16B	27.33	8.13%	3.56%	59.25%	88.37%
NHI	77 Outperform	$3.88B	25.57	10.87%	4.73%	8.04%	9.20%
SBRA	74 Outperform	$4.59B	25.24	6.29%	6.47%	8.12%	75.95%
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
LTC	62 Neutral	$1.75B	49.71	3.49%	6.70%	11.89%	-68.41%
DHC	49 Neutral	$1.46B	-4.10	-18.84%	0.80%	4.10%	8.96%
MPT	48 Neutral	$3.15B	-4.45	-14.02%	6.57%	45.56%	73.44%

Medical Properties Trust Corporate Events

Medical Properties Trust Announces Rebrand and Headquarters Relocation

On January 20, 2026, Medical Properties Trust marked its 20th year as a public company by unveiling a refreshed brand identity that includes changing its New York Stock Exchange ticker symbol from “MPW” to “MPT” effective February 2, 2026, updating its logo, simplifying its web domain and email addresses to MPT.com, and confirming the relocation of its corporate headquarters to a new, sustainability-focused facility at 10500 Liberty Parkway in Birmingham, Alabama. Management framed these initiatives as part of a broader effort to modernize the company’s image, support long-term sustainability and create a workplace designed to help employees “do their best work,” underscoring confidence in its hospital real estate business model after navigating market turbulence, tenant bankruptcies and other challenges, and signaling a continued emphasis on scale, resilience and value creation for shareholders and other stakeholders.

The most recent analyst rating on (MPW) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Medical Properties stock, see the MPW Stock Forecast page.

Medical Properties Announces $150 Million Stock Buyback

On October 28, 2025, Medical Properties Trust, Inc. announced a $150 million stock repurchase program, reflecting strategic financial management amid ongoing operational adjustments. The company reported a third-quarter net loss of $78 million, influenced by impairment charges, but highlighted increased cash rent collections and strategic agreements, such as the lease with NOR Healthcare Systems Corp. for California operations. The company’s efforts to stabilize and enhance its portfolio, including settlements and asset sales, indicate a focus on liquidity and debt management, aiming for over $1 billion in annualized cash rent by the end of 2026.

The most recent analyst rating on (MPW) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Medical Properties stock, see the MPW Stock Forecast page.